Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors

…, N Tomiyama, T Watabe, K Isohashi… - Journal of nuclear …, 2012 - Soc Nuclear Med
Recently, PET response criteria in solid tumors (PERCIST) have been proposed as a new
standardized method to assess chemotherapeutic response metabolically and quantitatively. …

[HTML][HTML] Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose …

…, K Akita, K Isohashi, T Aihara, K Nihei, K Ono - Radiation …, 2021 - Springer
Boron neutron capture therapy (BNCT) for the treatment of unresectable, locally advanced,
and recurrent carcinoma of the head and neck cancer has been approved by the Japanese …

[HTML][HTML] FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model

…, Y Kanai, H Ikeda, G Horitsugi, H Kato, K Isohashi… - EJNMMI research, 2014 - Springer
Background Boron neutron capture therapy (BNCT) is a molecular radiation treatment
based on the 10 B (n, α) 7 Li nuclear reaction in cancer cells, in which delivery of 10 B by 4-borono…

Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma

M Tatsumi, K Isohashi, K Matsunaga, T Watabe… - International Journal of …, 2019 - Springer
Purpose The purpose of this study was to determine if quantitative SUV-related, volumetric
FDG PET parameters, and texture features (SPs, VPs, and TFs, respectively) were useful to …

[HTML][HTML] Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT

T Watabe, M Tatsumi, H Watabe, K Isohashi… - Annals of nuclear …, 2012 - Springer
Objective Gastrointestinal stromal tumors (GISTs) and malignant lymphomas (MLs) in the
abdomen are often observed as tumors of unknown origin on F-18 FDG PET/CT. The purpose …

Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors …

K Nakajo, M Tatsumi, A Inoue, K Isohashi… - Japanese journal of …, 2010 - Springer
Purpose We compared the diagnostic accuracy of fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) and PET/magnetic resonance imaging (MRI) …

[PDF][PDF] Nociceptor-derived Reg3γ prevents endotoxic death by targeting kynurenine pathway in microglia

…, T Kondo, Y Kumagai, H Kato, Y Takayama, K Isohashi… - Cell Reports, 2022 - cell.com
Nociceptors can fine-tune local or systemic immunity, but the mechanisms of nociceptive
modulation in endotoxic death remain largely unknown. Here, we identified C-type lectin Reg3γ …

A novel PET index, 18F-FDG–11C-methionine uptake decoupling score, reflects glioma cell infiltration

…, H Arita, T Goto, Y Okita, K Isohashi… - Journal of Nuclear …, 2012 - Soc Nuclear Med
The linear correlation between 11 C-methionine PET and tumor cell density is not well
conserved at the tumor border in glioma. A novel imaging analysis method, voxelwise 18 F-FDG– …

18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT

M Tatsumi, K Isohashi, H Onishi, M Hori, T Kim… - International journal of …, 2011 - Springer
Objective To demonstrate that positron emission tomography (PET)/magnetic resonance
imaging (MRI) fusion was feasible in characterizing pancreatic tumors (PTs), comparing MRI …

Cell spray transplantation of adipose-derived mesenchymal stem cell recovers ischemic cardiomyopathy in a porcine model

…, K Kawai, H Kurata, H Nishida, K Isohashi… - …, 2018 - journals.lww.com
Background Allogeneic adipose-derived mesenchymal stem cells (ADSC) are promising
cell sources for cell therapy to treat ischemic cardiomyopathy (ICM). We hypothesized that …